Allogene Therapeutics ALLO Convertible Preferred Stock Issued Shares
Convertible Preferred Stock Issued Shares at other companies
Other financials
Where this comes from
Reported directly by Allogene Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesIssued.
The official record: Allogene Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Allogene Therapeutics's convertible preferred stock issued shares.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Allogene Therapeutics's convertible preferred stock issued shares?
- Allogene Therapeutics (ALLO) reported convertible preferred stock issued shares of 0 in Q1 2026.
- What does convertible preferred stock issued shares mean?
- Number of convertible preferred shares that have been issued, whether held by investors or in treasury.